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English abstract 
In this study we decided to throw light on some aspects of donkey’s 
helminthes infestation and control and the impact of treatment on liver and 
kidney function. 
In this study, 1256 animals were examined, 446 horses (Equus cabalus) 
and 810 donkeys (Equus asinus) during the period October 2006 to September 
2007, in South Darfur State, to investigate infection with gastro-intestinal 
nematodes. The overall prevalence of gastro-intestinal nematodes was 29.20%. 
November showed the highest incidence of infection (41.50%) while June the 
lowest incidence of infection (13.92%). The average arithmetic mean of egg per 
gram of faeces (epg) count was 589.97 ± 986.02 and the highest range reported 
was on April of 50-13450. The animals harbouring mild infection reported the 
highest incidence of 81.35%, while moderate infection reported 8.11% and 
10.54 for severe infection. The most prevalent genera of gastro-intestinal 
nematodes were Strongylus spp, Cyathostomes spp, Trichostrongylus spp, and 
Strongyloides westeri. 
Horses showed prevalence of 15.37%. In August showed we observed the 
highest incidence (100%), while in March was the lowest incidence (5.26%). 
Severity of infection reported were 82.35% for mild, 8.82% for moderate and 
8.82% for severe infection. Arithmetic mean of egg per gram of faeces (epg) 
count was 975.37±1099 and the highest range reported on November of 50-
13450. 
Donkeys showed 37.48% prevalence of gastro-intestinal nematodes. In 
January we observed the highest incidence of 55.79%, while in May we 
reported the lowest incidence 14.89%. Severity of infection showed 81.25% for 
mild, 7.89% for moderate and 10.86% for severe infection. Arithmetic mean of 
egg per gram of faeces (epg) count was 750.14±1071.95 and the highest range 
reported was in April 50-11800. 
The therapeutic efficacy of Albendazole and Ivermectin drench 
formulation at the manufacturers recommended dose were evaluated in 
controlled trial at Nyala town, South Darfur State, Sudan. The study involved 
24 donkeys naturally infected with gastrointestinal nematodes; they were 
divided into four groups of equal size. Albendazole was administered orally 
once at dose rate of 10 mg/kg body weight for group one (ALB1) and twice 
with interval of 14 days post treatment at the same dose rate of 10 mg/kg body 
weight for group two (ALB2). Ivermectin was administered orally as single 
dose at 200 µg/kg body weight for group three (IVMT), group four was left 
without treatment as a control. Treatment efficacy was based on the mean faecal 
egg count reduction 14 days post treatment. A faecal egg count reduction of 
100% was found after treatment with Albendazole, Albendazole twice and 
Ivermectin. At necropsy efficacy percentages of Albendazole, Albendazole 
twice and Ivermectin against adult nematode were as follows: Trichostrongylus 
axei 67.09%, 100% and 100%; Parascaris equorum 100%, 100% and 100%; 
Oxyuris equi 100%, 100% and 100%, Strongylus sp. 98.4%, 100% and 98.81%; 
and small strongyles 91.7%, 99.5% and 96.5%. Albendazole, Albendazole twice 
and Ivermectin with the single dose showed low to moderate efficacy (33%, 
48.84% and 62.71%, respectively) against larvae found the cranial mesenteric 
artery aneurisms.  No adverse reactions were observed in treated donkeys 
during the experiment period.  
Blood samples were also collected from the above treated animals to 
examine the effect of treatment on different biochemical parameters. Blood 
samples were collected at day 0, 1, 3, 7, 14 and 21 days post treatment, then 
serum biochemical analysis was conducted using commercial kits. Although, 
results obtained showed significant changes during some sampling times but all 
the values were within the normal range suggested by other researchers. All 
parameters tested were within the normal range by the end of the study.  
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 41 ﺑﺎﻟﻔﻢ ﺑﻔﺎﺻﻞ ﺯﻣﲏ ﻗﺪﺭﻩ ﻮﻳﺔ ﻭﺍﺣﺪﺓ ﻣﻦ ﻋﻘﺎﺭ ﺍﻟﺒﻨﺪﺍﺯﻭﻝ ﺑﻴﻨﻤﺎ ﺗﻠﻘﺖ ﺍﻤﻮﻋﺔ ﺍﻟﺜﺎﻧﻴﺔ ﺟﺮﻋﺘﲔ ﺃﻳﻀﺎﹰ ﺟﺮﻋﺔ ﻓﻤ 
 ﺍﻤﻮﻋﺔ ﺍﻟﺜﺎﻟﺜﺔ ﺗﻠﻘﺖ ﺟﺮﻋﺔ ﻓﻤﻮﻳﺔ ﻭﺍﺣﺪﺓ ﻣﻦ ﻋﻘﺎﺭ ﺍﻻﻳﻔﺮﻣﻜﺘﲔ ﺑﻴﻨﻤﺎ ﰎ ﺍﻻﺣﺘﻔـﺎﻅ ﻳﻮﻡ ﻣﻦ ﻋﻘﺎﺭ ﺍﻟﺒﻨﺪﺍﺯﻭﻝ، 
ﺍﻟﺘﺠﺮﺑﺔ ﰲ ﺗﻘﺪﻳﺮ ﻓﻌﺎﻟﻴﺔ ﺍﻟـﺪﻭﺍﺋﲔ ﻋﻠـﻲ ﺍﻋﺘﻤﺪﺕ . ﺑﺎﻤﻮﻋﺔ ﺍﻟﺮﺍﺑﻌﺔ ﺩﻭﻥ ﻋﻼﺝ ﻟﻠﺘﺤﻜﻢ ﻭ ﺍﳌﻘﺎﺭﻧﺔ ﻓﻴﻤﺎ ﺑﻌﺪ 
 ﺍﻟﻘﺘﻞ ﺍﻟﺮﺣﻴﻢ ﰲ ﺍﻟﻴـﻮﻡ ﰎ ﺇﺟﺮﺍﺀ  ﻳﻮﻣﺎ ﻣﻦ ﲡﺮﻳﻊ ﺍﻟﺪﻭﺍﺀ ﻭ ﻣﻦ ﲦﺔ 41ﺍﻻﳔﻔﺎﺽ ﰲ ﺗﻌﺪﺍﺩ ﺍﻟﺒﻴﺾ ﺍﻟﺮﻭﺙ ﺧﻼﻝ 
ﺍﳊﺎﺩﻱ ﻭ ﺍﻟﻌﺸﺮﻳﻦ ﻣﻦ ﲡﺮﻳﻊ ﺍﻟﺪﻭﺍﺀ ﻭ ﺫﻟﻚ ﻟﻔﺤﺺ ﳏﺘﻮﻱ ﺍﻟﻘﻨﺎﺓ ﺍﳍﻀﻤﻴﺔ ﻣﻦ ﺍﻟﺪﻳﺪﺍﻥ ﺍﻻﺳـﻄﻮﺍﻧﻴﺔ ﺍﳌﻌﺪﻳـﺔ 
  .ﺍﳌﻌﻮﻳﺔ
ﻭ . ﻟﻠﺜﻼﺛﺔ ﳎﻤﻮﻋﺎﺕ ﺍﳌﻌﺎﳉـﺔ % 001ﺎﺽ ﺗﻌﺪﺍﺩ ﺍﻟﺒﻴﺾ ﰲ ﺯﻧﺔ ﺟﺮﺍﻡ ﻣﻦ ﺍﻟﺮﻭﺙ ﻛﺎﻥ ﺑﻨﺴﺒﺔ             ﺍﳔﻔ
% 001ﻭ % 001ﻭ % 90.76ﺑﻠﻐـﺖ ﻧـﺴﺒﺔ ﺍﻟﻔﻌﺎﻟﻴـﺔ ﰲ ﻣﻌﺎﳉـﺔ ﺃﻧـﻮﺍﻉ ﺍﻟﺪﻳـﺪﺍﻥ ﺍﻻﺳـﻄﻮﺍﻧﻴﺔ 
. murouqe siracsaraPﳉـ ــﻨﺲ % 001ﻭ % 001، %001. iexa sulygnortsohcirT
 ﳉــﻨﺲ %18.89 ﻭ %001 ،%4.89. iuqe siruyxOﳉــﻨﺲ % 001ﻭ% 001، %001
 ﻟﻜﻞ ﻣﻦ selygnortS llamsﻛﺎﻧﺖ ﻷﺟﻨﺎﺱ % 5.69 ﻭ ،%5.99 ،%7.19 . .pps sulygnortS
ﺍﻟﻌﻘﺎﺭﺍﻥ ﺃﺑﺪﻳﺎ ﺩﺭﺟﺔ ﻓﻌﺎﻟﻴﺔ . ﻋﻘﺎﺭ ﺍﻟﺒﻨﺪﺍﺯﻭﻝ ﺑﺎﳉﺮﻋﺔ ﺍﻟﻌﺎﺩﻳﺔ ﰒ ﺍﳉﺮﻋﺔ ﺍﳌﻀﺎﻋﻔﺔ ﻭ ﻋﻘﺎﺭ ﺍﻻﻳﻔﺮﻣﻜﺘﲔ ﻋﻠﻰ ﺍﻟﺘﻮﺍﱄ 
% 17.26ﻟﻠﺒﻨﺪﺍﺯﻭﻝ ﺑﺎﳉﺮﻋـﺔ ﺍﳌـﻀﺎﻋﻔﺔ ﻭ % 48.84ﻟﻠﺒﻨﺪﺍﺯﻭﻝ ﺑﺎﳉﺮﻋﺔ ﺍﻟﻌﺎﺩﻳﺔ % 33ﻣﺘﻮﺳﻄﺔ ﺑﻠﻐﺖ 
 ﺍﳌﺘﻐﺬﻳـﺔ ﻋﻠـﻰ ﺍﻟـﺪﻣﺎﺀ ﺑﺎﻟـﺸﺮﻳﺎﻥ pps sulygnortSﻟﻼﻳﻔﺮﻣﻜﺘﲔ ﰲ ﻋﻼﺝ ﻳﺮﻗﺎﺕ ﺍﻟﻄﻮﺭ ﺍﻟﺜﺎﻟﺚ ﻟﺪﻳﺪﺍﻥ 
  .ﺍﳌﺴﺎﺭﻳﻘﻲ ﺍﻟﻘﺤﻔﻲ ﻭ ﻓﺮﻭﻋﻪ
 81 ﺍﻻﺳﺘﻄﺒﺎﰊ ﺑﻌﻘﺎﺭﻱ ﺍﻟﺒﻨﺪﺍﺯﻭﻝ ﺍﳌﻌﻠﻖ ﻭ ﺍﻻﻳﻔﺮﻣﻜﺘﲔ ﺍﻟﺸﺮﺍﺏ ﰲ              ﺃﺟﺮﻳﺖ ﺩﺭﺍﺳﺔ ﺛﺎﻧﻴﺔ ﻟﺘﻘﻴﻢ ﺍﻷﺛﺮ 
ﻗﺴﻤﺖ ﺍﳊﻴﻮﺍﻧﺎﺕ ﺑﺎﻟﺘـﺴﺎﻭﻱ ﺍﱄ . ﻣﻦ ﺫﻛﻮﺭ ﺍﳊﻤﲑ ﺫﺍﺕ ﺍﻹﺻﺎﺑﺔ ﺍﻟﻄﺒﻴﻌﻴﺔ ﺑﺎﻟﺪﻳﺪﺍﻥ ﺍﻻﺳﻄﻮﺍﻧﻴﺔ ﺍﳌﻌﺪﻳﺔ ﺍﳌﻌﻮﻳﺔ 
ﺗﻠﻘﺖ ﺍﻤﻮﻋﺔ ﺍﻻﻭﱃ ﺟﺮﻋﺔ ﻓﻤﻮﻳﺔ ﻭﺍﺣﺪﺓ ﻣﻦ ﻋﻘﺎﺭ ﺍﻟﺒﻨﺪﺍﺯﻭﻝ ﺑﻴﻨﻤﺎ ﺗﻠﻘﺖ ﺍﻤﻮﻋﺔ ﺍﻟﺜﺎﻧﻴـﺔ ، ﺛﻼﺙ ﳎﻤﻮﻋﺎﺕ 
ﺍﻤﻮﻋﺔ ﺍﻟﺜﺎﻟﺜﺔ ﺗﻠﻘﺖ ﺟﺮﻋﺔ ﻓﻤﻮﻳﺔ ﻭﺍﺣﺪﺓ ، ﻨﺪﺍﺯﻭﻝ ﻳﻮﻡ ﻣﻦ ﻋﻘﺎﺭ ﺍﻟﺒ 41 ﺑﺎﻟﻔﻢ ﺑﻔﺎﺻﻞ ﺯﻣﲏ ﻗﺪﺭﻩ ﺟﺮﻋﺘﲔ ﺃﻳﻀﺎﹰ 
 ﻣﻦ ﺍﻟﻌﻼﺝ ﻭ ﻣﻦ ﺑﻌﺪ 12ﻳﻮﻡ "  ﻭ ﺃﺧﲑﺍ 41 ،7، 3 ،1 ﻳﻮﻡ ﺻﻔﺮ، ﲨﻌﺖ ﺍﻟﻌﻴﻨﺎﺕ ﰲ . ﻣﻦ ﻋﻘﺎﺭ ﺍﻻﻳﻔﺮﻣﻜﺘﲔ 
 ﺍﺧﺘﻼﻓﺎﺕ ﺍﻟﻨﺘﺎﺋﺞﺳﺠﻠﺖ . ﺍﻟﱵ ﰎ ﲨﻌﻬﺎ ﺧﻼﻝ ﺍﻟﺘﺠﺮﺑﺔ ﺫﻟﻚ ﺍﺟﺮﻱ ﺍﻟﺘﺤﻠﻴﻞ ﺍﻟﻜﻴﻤﻮﺣﻴﻮﻱ ﻋﻠﻰ ﻋﻴﻨﺎﺕ ﺍﳌﺼﻞ 
 ﻭ ﻟﻜﻦ ﻏﺎﻟﺐ ﺍﻻﺧﺘﻼﻓﺎﺕ ﻛﺎﻥ ﺿﻤﻦ ﺍﳌـﺴﺘﻮﻯ ﺍﻟﻄﺒﻴﻌـﻲ ﻭ ﺍﻟﺰﻣﻨﻴﺔ ﺧﻼﻝ ﺍﻟﺘﺠﺮﺑﺔ ﺍﻟﻔﺘﺮﺍﺕ ﻣﻌﻨﻮﻳﺔ ﰲ ﺑﻌﺾ 
  . ﻛﻞ ﺍﻟﻘﺮﺍﺀﺍﺕ ﻛﺎﻧﺖ ﺿﻤﻦ ﺍﳌﺴﺘﻮﻯ ﺍﻟﻄﺒﻴﻌﻲ ﰲ ﺎﻳﺔ ﺍﻟﺘﺠﺮﺑﺔ" ﻋﻤﻮﻣﺎ
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Introduction 
 
In Sudan, donkeys are becoming increasingly important in view of their 
increased use instead of horses in labour as drought animals as well as carrying 
water, and in transportation. This present situation can be observed in many 
urban and suburban areas. Moreover, donkeys are used as pack beasts and in 
ploughing. As in many other developing countries donkeys in Sudan play and 
constitute an important source of cheap energy for agricultural production by 
way of traction for cultivation and transport of produce, goods and labour. 
With regard to livestock population, Sudan constitutes one of the richest 
African and Arab countries. Most of these animals are owned by nomadic or 
semi-nomadic tribes living in the semi arid regions. Livestock population was 
reported to be about 121 million head, composed of 35.825, 44.802, 37.346, 
3.031, 0.65 and 6.35 million head of cattle, sheep, goats, camels, horses and 
donkeys respectively (SBAR, 2000). However, donkeys’ population is 
relatively large compared to camels and horses. About 30.9% of donkeys’ are 
found in Darfur States. 
Horses, ponies and donkeys are hosts to a large population of parasites 
(Duncan, 1983). Lichtenfels  (1975) stated that; equids are hosts for helminths 
belonging to 28 genera and 75 species of nematodes, 2 genera and 5 species of 
trematodes as well as 3 genera and 24 species of cestodes. 
  Helminth parasite infection was the main problem reported in donkeys 
admitted to veterinary clinic (Ali et al., 2001). Seri and his colleagues (2004) 
showed that the prevalence of nematodes infection in donkeys in Khartoum 
state was 70.1%. Kheir and Kheir (1981) conducted field survey in South 
Darfur State, Sudan, and stated that the prevalence was 56.2% and overall 
prevalence of infection with nematode parasites was (58%) in town animals and 
(22%) in nomadic areas. In Sennar; of the 218 donkeys examined for parasitic 
infestation, 193 donkeys were positive and the prevalence was 88.53% (El 
Dirdiri et al., 1986). 
Parasites may cause many effects to their hosts (equines): suck blood, 
often which cause anaemia and even death; penetrate and destroy the mucosal 
cell, severely impairing the host ability to digest and absorb nutrients; 
physically obstruct the gut lumen; the damage of other tissues which caused by 
migrating larvae (Brander et al., 1982).      
The health and welfare of the donkey is of crucial importance to those 
who depend on it for their livelihood. Should a donkey fall out of work or die, 
the family depending on it may suffer great hardships and even non-recoverable 
adversities. 
Before 1960 the two most widely used compounds for the control of adult 
strongyle worms and Parascaris equorum, and some of the less important horse 
worms, were Phenothiazines and Piperazines (Gibson, 1975). And since the 
introduction in the early 1960s of the first broad spectrum anthelmintic 
Thiabendazole, followed shortly afterward by Tetramisole, there have been 
virtual processing of new highly effective broad spectrum anthelmintic and 
considerable confusion reigns as to the merits of the different drugs (Armour 
and Bogan, 1982). 
 Details such as the number and timing of treatments recommended in 
different areas of the world vary according to local conditions, including 
management practices, environmental factors and availability of drugs. 
Evaluation of anthelmintics is determined consequent upon knowledge of the 
epidemiology of the parasites to be treated and their importance in the 
economics of the production.  
The prominent importance of donkeys in the Sudan coupled with rarity 
and scantiness of data and information concerning helminth parasites infestation 
and treatment in this species of domestic animals seems to justify the current 
study. 
Objectives 
The main objectives of this study are: 
1. To determine the prevalence of the gastrointestinal helminths of equines in 
South Darfur State. 
2. To investigate the therapeutic efficacy of the drugs under study against 
gastrointestinal nematodes of donkeys. 
3. To report on the post treatment biochemical changes, if any. 
 
Literature review 
1.1 Albendazole 
Benzimidazole anthelmintics have a broad spectrum of activity against 
gastrointestinal helminths, including migrating strongyle larvae and lungworm 
infections, and are well tolerated by mammals (McKellar and Scott, 1990).  
All benzimidazoles have been developed as a result of the extensive 
studies that were carried out in a number of laboratories to modify the structure 
of thiabendazole. A feature of the newer structures is that they are metabolised 
and excreted much more slowly than thiabendazole. This is achieved by 
blocking the 5-position. The substitutions of another group in the 5-position, 
and the replacement of the thiazole ring by methyl carbamate, have a very 
significant effect on the rate of elimination (Brander et al., 1982). The 
differences in efficiency between members of this class of drugs against groups 
of parasites probably reflect differences in bioavailability of the drugs within 
the host animal (McKellar and Scott, 1990). 
Benzimidazoles have a low mammalian toxicity and it have proved 
impossible to find an LD50 for some of these compounds. Oxenfendazole and 
albendazole are teratogenics, and depending on the dose rate, should not be used 
in early pregnancy (Armour and Bogan, 1982). In vitro turbidimetric techniques 
and competitive colchicine-binding studies demonstrated the inhibitory power 
of benzimidazoles on the polymerization of tubulin into microtubules. The 
difference in the sensitivity of host and parasites to the effects of 
benzimidazoles may be due to difference in the structure of microtubules in 
their cells (Davis and Gull, 1983). 
1.1.1 Identity  
Albendazole is a member of the benzimidazole group. It is orally 
administered broad-spectrum anthelmintic, soluble in dimethylsulphoxid, strong 
acids and strong bases. It is slightly soluble in methanol, chloroform, ethyl 
acetate and acetonitrile. Albendazole is practically insoluble in water. 
1.1.2 Chemical name  
Methyl [5-(propylthio)-1H benzimedazole-2 yl] carbamate.   
1.1.3  Molecular formula 
C12 H15 N3 O2 S. 
1.1.4 Molecular weight 
265.34 
1.1.5 Appearance 
It is pale green powder. The recent commercial products are white to off-
white (Brander et al., 1982). 
1.1.6 Structural formula 
 
1.1.7 Mode of action: 
           The inhibition of the fumerate reductase system appears to be the mode 
of action of the drug, which appears to act on the parasite by absorption 
through the cuticle (Brander et al., 1982). Albendazole is thought to act by 
binding to parasite -tubulin, inhibiting its polymerization and impairing glucose 
uptake. Albendazole is initially oxidized to albendazole sulphoxide, an active 
drug, and then further oxidized to albendazole sulphone, which is inactive 
(Moskopp and Lotterer, 1993).  
1.1.8Toxicity of Albendazole 
Acute toxicological effects 
          World health organization (WHO), the food additive series 25 reported 
findings in dead rats included, urinary staining of abdomen, bloody discharge 
around nose, and intestinal haemorrhage. Also in another study, necropsy of 
dead rabbits showed intestines containing fluid dilated with gas. 
Short term toxicological effects 
Mice 
Two groups of both males and females treated with albendazole in 
different doses for three months. All the females and 50% of the males of the 
highest dose 1600 mg/kg bw (160 times the recommended dose) died 
spontaneously or killed in a moribund condition. From week 9, ear lesions 
involving thickening and/or encrustation of the lip were observed in 20% of the 
males and 22.2% of the females at 800 mg/kg bw (80 times the recommended 
dose), and 100% of the males at 1600 mg/kg bw. Food consumption was 
generally decreased in males given 400 mg/kg bw (40 times the recommended 
dose) or more but body weight gain was depressed only at1600 mg/kg bw. At 
the end of the study haemoglobin (Hb), haematocrit and erythrocyte levels were 
reduced at dose of 800 mg/kg bw or more also decreased leucocyte counts 
observed in males at (800 mg/kg bw) (Daly and Rinehart, 1980). 
Post mortem examination revealed increase in absolute and relative liver 
weight at 40 mg/kg bw (4 times the recommended dose) in males and 80 mg/kg 
bw (8 times the recommended dose) in females (Daly and Rinehart 1980). 
Rats 
The toxic signs following administration of higher doses more than 48 
mg/kg bw, (4.8 times the recommended dose) were diarrhoea, piloerection, 
nasal swelling with blood stained, nasal discharge, death and body weight 
depressed. Haemoglobin, haematocrit, erythrocyte and leucocyte counts were 
reduced (Simon, 1979a). 
At high doses 48 and 168 mg/kg bw, (4.8 and 16.8 times the 
recommended dose respectively), adrenal size was increased particularly in 
females. Testes were reduced in size at 48 mg/kg bw (Simon, 1979a). 
Histopathology revealed hypoplasia in testes, bone marrow, spleen and lymph 
nodes at 48 and 168 mg/kg bw (Simon, 1979). 
At dose of 45 mg/kg bw (4.5 times the recommended dose) plasma 
cholesterol was increased in males and females, potassium was increased in 
males and albumin, plasma and erythrocyte cholinesterase were decreased in 
females, and urinary protein was increased at 30 and 45 mg/kg bw (3 and 4.5 
times of recommended dose, respectively) (Daly and Hogan, 1982). 
Numerous gross alternations were noted with high doses in post mortem 
including discoloration and/or nodules in the lungs, heart, lymph nodes, spleen, 
pancreas, liver, adrenal and kidneys. Some of these organs were also enlarged 
or showed adhesions. And thymic tissue was often absent and testes were small 
and flaccid (Daly and Hogan, 1982). 
Histopathology carried out identified a number of instances, where 
bacterial colonization in lung, spleen, kidney, and heart was associated with 
necrosis without the usual acute inflammatory response (Daly and Hogan, 
1982). 
Long term toxicological effects 
Mice 
Long-term toxicological studies in mice revealed decrease in erythrocyte 
and leucocyte counts without toxic signs or effects on food intake and body 
weight (Selwyn, 1987). Histopathological tests carried out indicated flaccid or 
small testes, testicular tubular degeneration and oligospermia (Selwyn, 1987). 
Rats 
Studies carried in rats, showed decrease of total leucocytes neutrophil 
counts, serum cholesterol was increased in some sampling times (Sauer 1985). 
Post mortem findings and histopathology revealed in rats treated at 20mg/kg bw 
(2 times of recommended dose) were increased incidence of flaccid testes (Daly 
and Knezevich, 1987). Degeneration, atrophy of germinal and relative liver 
weight in males and hepatic fatty metamorphosis in both males and females 
(Daly and Knezevich, 1987). 
Reproductive toxicological effects 
In a group of rats fed diet containing albendazole at different doses for 
three successive generations. There were no toxic sings, body weight, food 
consumption, mating, fertility, pregnancy rate and gestation length, were 
normal. During lactation weight gain depressed but only in F1 and F2 
(Schroeder and Rinehart, 1980). In female rats uterine examinations in gestation 
day 13 showed fewer implantation (not significant) at dose of 30 mg/kg bw (3 
times the recommended dose) with no effect on resorption (Boutemy, 1980). 
Genotoxic effects 
Studies on Chinese hamster ovary cells indicated negative result for 
genotoxicosis by albendazole (Galloway, 1981). 
Teratogenic effects 
Mice 
There was no overt maternal toxicity or effects on resorption incidence, 
foetal weight and external-visceral and skeletal development of foetus following 
administration of albendazole (Killeen and Rapp, 1975). 
Rats 
At dose of 6 - 62 mg/kg bw (0.6 and 6.2 times of recommended dose) 
skeletal abnormalities were increased and greater with increases in resorption 
and external malformations, decreased foetal weight. The major malformations 
were cranio-facial and bone defect (Martin, 1980). The dose of 30 mg/kg bw (3 
times the recommended dose) showed foetal limbs abnormalities (Christian, 
1984). 
At 40 mg/kg bw (4 times the recommended dose) no toxicity or effect on 
gestation and parturition. Small lungs and anasarca possibly related to treatment 
in foetus (Johnson, 1981). 
Rabbits 
In rabbits, the maternal mortality was increased in 30 mg/kg bw (3 times 
the recommended dose) and reduction in implantation in gestation day 7 – 19 
(Killeen and Rapp, 1975). 
Sheep  
The pregnant ewes given albendazole in gestation day 17 were allowed to 
deliver naturally, but premature delivery in more ewes was noted. All premature 
lambs were stillborn; consequently the number of live lambs was reduced. Post-
mortem revealed increased incidence of prognathia, scoliosis, spinal bifid, 
reduced tail and poorly developed or absent kidneys (Tash and Harper, 1977). 
1.1.9 Pharmacokinetics 
Mice 
The single gavage dose of albendazole C14-ring labelled albendazole 
given to mice revealed, over 72 hours period, that 20.5% of the administered 
dose was recovered in the urine. Albendazole sulphoxide and two other 
metabolites accounted for 81% of label. Low level of parent drug, albendazole 
sulphoxide and three other metabolites were detected (Parish et al., 1979a). The 
sulphone metabolite has higher plasma level than sulphoxide (Souhaili El Amri 
et al., 1988). Both the sulphoxide and the sulphone metabolites decreased to 
very low levels at 18 hours (Delatour et al., 1984). 
       Albendazole induces certain hepatic drug-metabolising enzymes, which 
may be responsible for the enhancing degradation of sulphoxide to sulphone 
following repeated administration (Souhaili El Amri et al., 1988). 
Rats 
In rats 31% of administered radioactive dose was recovered in the urine 
over 72 hours period. Sulphoxide, 2-aminosulphone and three other metabolites 
accounted for 89% of the label. Albendazole sulphone and two other 
metabolites were also found (Parish and Gyurik, 1979). The sulphoxide and the 
sulphone derivatives resulted in the urinary excretion. The urinary metabolites 
were qualitatively similar to those observed after albendazole administration 
(Parish and Gyurik, 1979). 
Sheep 
Albendazole was absorbed unchanged from the rumen and passed 
through the stomach while the metabolites were secreted or diffused in this 
organ (Marianer and Bogan, 1980). 
After single oral dose of labelled albendazole on day 1, in the liver the 
label was mainly on form of sulphoxide and sulphone metabolites, which were 
progressively converted to 2-amino sulphone which was the primary metabolite 
on day 8. Over 72 hours the sulphoxide and 2-amino sulphone accounted 60 – 
70% of urinary excretion of the drug. Low levels of parent drug and the 
sulphone with 6 other metabolites were detected (Colman et al., 1977). 
Cattle 
The metabolism to the sulphoxide and the sulphone was rapid and the 
compounds were present in plasma for up to 40 hours (Prichard et al, 1985).             
In calves at dose of 20 mg/kg bw (4 times the recommended dose), over 7 days 
period 47% of the administered dose was recovered in urine; the sulphoxide, 
sulphone and 2-amino sulphone accounted 70% of the excreted dose (Parish et 
al.,1977 )           
Although albendazole excreted in the animal’s milk, biliary elimination 
presumably accounts for a portion of the elimination as evidenced by biliary 
concentrations of albendazole similar to those achieved in the plasma.            
Limited examinations of kidney revealed a similar metabolic profile (Kaeer et 
al., 1977) 
Human 
Oral bioavailability of albendazole appears to be enhanced when it is co-
administered with a fatty meal as evidenced by higher plasma concentrations of 
albendazole sulphoxide as compared to the fast state. Albendazole not detected 
in plasma, but its main metabolites could be found and the half-life of 
albendazole sulphoxide is 10 and 15 hours (Jung et al., 1992). 
Albendazole sulphoxide is 70% bound to plasma protein and is widely 
distributed through the body; it has been detected in urine, bile, liver, cyst wall, 
cyst fluid and cerebral spinal fluid (CSF). Analysis of the urine showed the 
presence of the sulphoxide, the sulphone and their amino derivatives with three 
other metabolites (Rossignol and Maisonneuve, 1984). 
Equine  
Albendazole when given to donkeys at dose of 10 mg/kg bw; the parent 
molecule of the drug was not detected in the plasma, but its sulphoxide and 
sulphone metabolites were detected, demonstrating that albendazole was 
completely metabolised by first-pass mechanism in donkeys. The sulphoxide 
metabolite of albendazole was significantly higher than that of the sulphone 
metabolite (Gokbulut et al., 2005). 
Faecal concentration of parent molecule of the drug after albendazole 
administration was significantly metabolised, probably by gastro-intestinal 
microflora, to its sulphoxide metabolites that showed a similar profile to the 
parent molecule in the faecal sample (Gokbulut et al., 2005). Plasma 
concentration of albendazole was significantly lower when compared with 
oxifendazole (Gokbulut et al, 2005). 
Benzimidazoles are extensively metabolized in all animal species. 
Generally, the plasma elimination half-lives of the parent drugs are short and 
the metabolic moieties predominate in plasma and tissues and in the excretion  
of the host as well as in parasites recovered from Benzimidazole-treated animals 
(Lanusse and Prichard, 1993; Delatour and Parish, 1986). 
The less soluble Benzimidazole compounds have a longer residence in 
the fore stomachs of ruminants from which they are absorbed over prolonged 
periods and thus remain in the plasma for a relatively long time. Since an 
equilibrium exists between the plasma and gastrointestinal tract, the duration of 
exposure of gut parasites to an effective concentration of the drug is extended 
(Mackellar and Scott, 1990). Extremely insoluble anthelmintics may be less 
effective, since they may not be absorbed and are excreted unchanged in the 
faeces. This may explain the difference between the plasma concentrations of 
oxfendazole (fenbendazole sulphoxide, FBZSO) following oral administration 
and its inter-convertible metabolite fenbendazole (FBZ) (Ngomuo et al., 1984). 
A large proportion of the less soluble FBZ is known to be excreted in the faeces 
of ruminants (Duwel, 1977). 
Oxfendazole, fenbendazole and albendazole (ABZ) are commercially 
available sulphur-containing benzimidazoles that commonly undergo 
microsomal oxidation in liver. Sulphide benzimidazoles (FBZ and ABZ) are 
reversibly metabolized to their sulphoxide derivatives (Marriner and Bogan, 
1980, 1981; Gyurick et al., 1981; Mohammed Ali et al., 1987). Irreversible 
sulphonation follows sulphoxidation and is a slower oxidative step resulting in a 
sulphone metabolite (Averkin et al., 1975). 
The pharmacokinetics of FBZ and FBZSO have been studied in horses in 
which the metabolic inter-conversion of those compounds appears to differ 
substantially from ruminants. In the horse, the bioavailability and residence time 
of the tested benzimidazoles (and metabolites) were lower and shorter, 
respectively, than in ruminants (Mckellar et al., 2002; Gokbulut, 2000; Marriner 
and Bogan, 1985, 1981). 
Sulphide and sulphoxide benzimidazoles are known to bind to nematode 
tubulin (Lacey et al., 1987) and therefore have activity against nematode 
although sulphides exert an inhibitory activity on tubulin at lower 
concentrations than sulphoxides. In most species examined, the sulphoxide 
moiety predominates in plasma and is thought to confer activity against gut 
dwelling nematodes following secretion across the gastrointestinal wall into the 
gut lumen where it may undergo sulpho-reduction (Mckellar and Scott, 1990). 
Maximum plasma concentration (Cmax) of albendazole sulphoxide 
(ALBSO) (0.08µg/mL) and albendazole sulphone (ALBSO2) (0.04 µg/mL) 
were obtained at (tmax) 5.71 and 8.00 h respectively, following administration of 
albendazole. The area under the curve (AUC) of the sulphoxide metabolite 
(0.84 µg.h/mL) of ABZ was significantly higher than that of the sulphone 
metabolite (0.50 µg.h/mL).  
Although (ABZ) is not licensed for use in Equidae. Its metabolites 
presented a greater plasma kinetic profile than FBZ which is licensed for use in 
horses. A higher metabolic capacity, first-pass effects and lower absorption of 
benzimidazoles in donkeys decrease bioavailability and efficacy compared to 
ruminants (Gokbulut et al., 2005). 
1.1.10 Use of Albendazole in animals 
Cattle 
Albendazole had been shown to be highly effective against lungworms; 
also it is very active against adult liver flukes in cattle when given at twice the 
recommended dosage rate for roundworm therapy (Armour and Bogan, 1982).  
Sheep 
Albendazole is effective in chronic fasciolaisis treatment, also 
albendazole is certainly effective against the adult and developing larval stage 
of D. filarial and naturally occurring infection with the other small lungworms 
in sheep and goat (Armour and Bogan, 1982). 
Equine 
There is a paucity of data available in the literature on the toxic or side 
effects in equine and albendazole is not used in these species (Gokbulut et al., 
2005). A higher metabolic capacity, first-pass effects and lower absorption of 
benzimidazoles in donkeys decrease bioavailability and efficacy compared to 
ruminants (Gokbulut et al., 2005).  
High intestinal concentrations could be effective against gastrointestinal 
nematodes that inhabit the gut lumen, but very low plasma concentrations of 
albendazole may not be effective against migrating fourth larval stages of large 
strongyles or lung worms. Repeated dosage regimes of albendazole or co-
administration with metabolic inhibitors could be used to treat migrating larval 
or tissue stages of strongyles and lungworms in donkeys (Gokbulut et al, 2005).  
       10 mg/kg BW of albendazole may be used for treatment of 
strongyloidosis of horses and donkeys (Kassai, 1999). In Kentucky agricultural 
experiment station, tests were conducted between February 1977 and June 1981 
using 10 adolescent horses which were proved to be naturally infected with 
population B small strongyles. Effective reductions (97% to 100%) were 
recorded for treatments with Oxibendazole, Albendazole, and Thiabendazole. 
The larval count indicated that all of the compounds were 100% effective in 
removing larvae of S. vulgaris and S. edentates. Albendazole removed 94% to 
100% of 11 species and 84% of the 12th species (Cyathostomum coronatum). 
Removal of immature small strongyles by oxibendazole and albendazole in the 
tests (15% and 38%) was somewhat less than the 71% for Oxibendazole in an 
earlier study (Drudge et al., 1979). Population B small strongyles have been 
reported to be resistant to thiabendazole, fenbendazole, and oxfenbendazole but 
not to oxibendazole (Drudge et al., 1979). Five species of small strongyles were 
resistant, whereas 19 species of small strongyles and 2 species of large 
strongyles (Strongylus vulgaris and Strongylus edentates) were removed 
efficaciously by all six benzimidazoles. Albendazole is closely related analogue 
of oxibendazole and is active against the 5 species of Benzimidazole resistant 
small strongyles. 
Worm counts indicated that the efficacy of albendazole against larval stages 
of small strongyles, measured as the percentage of worms removed by 
albendazole treatment was limited, particularly for L3. The efficacy of 
albendazole against these helminth adults was somewhat higher, but 
considerable differences between species also were observed (Eysker et al., 
1988). 
The effect of albendazole against larval stages was lower than that against 
adult worms; this low effect mainly is the result of a limited efficacy of 
albendazole against larval stages (Drudge et al., 1984). Low efficacy of 
albendazole treatment can be a result of anthelmintic resistance (Eysker et al., 
1988) 
  Benzimidazole resistance is a common phenomenon in Cyathostomes. It 
has been recorded in 5 species of Cyathostomes by Drudge et al., (1979). 
In a series of experiments on the epidemiology and control of 
cyathostome infections in Shetland ponies between 1984 and 1986, the effect of 
repeated early-season albendazole (Eysker et al., 1986, 1988) and oxfendazole 
(Eysker et al., 1989) treatments was evaluated. The results of these studies 
invariably showed reduction in faecal egg output after the first treatment but 
poor effect of later treatments. 
Apparently the repeated use of one Benzimidazole within one grazing 
season is of little prophylactic value (Eysker et al., 1989a). An important aspect 
of the epidemiology of cyathostome infections in equids is the occurrence of 
inhibited development. Gibson (1953) observed that some weeks after each of a 
series of phenothiazine treatments, strongyle-type eggs reappeared in the faeces 
of horses, even after housing period under helminth-free conditions of 3 years. 
His explanation of this phenomenon was the existence of an equilibrium 
between inhibited larvae in, and adult worm on, the gut wall leading to 
resumption of development of inhibited larvae after removal of adult worms. 
Later, Ogburne (1975) found evidence for an emergence of fourth-stage 
larvae (L4) from the intestinal wall at the end of the winter, indicating a 
seasonal pattern of inhibited development similar to many Trichostrongylidae of 
ruminants. 
Anthelmintics resistance in cyathostomin nematodes (‘small strongyles’) of 
horses is a well-known phenomenon worldwide. Benzimidazole (BZ) resistant 
cyathostomins have been reported from North and South America, South 
Africa, Australia. New Zealand and many European countries (reviewed by 
Kaplan, 2002) including Greece (Papadopoulos et al., 2000).  
Benzimidazole resistant populations of cyathostomin nematodes were 
detected on seven of ten Turkish horse farms (Cirak et al., 2004). According to 
FECRT data, Benzimidazole resistance in stronglyids was observed only at 
Dubrovsky (Ukraine) horse farm (FECRT=68%). No resistance to macrocyclic 
lactones in strongylids or in Parascaris equorum was observed (Kuzmina and 
Kharchenko, 2008). BZ resistance in horse strongylid nematodes in Ukraine 
was found only in cyathostomins, or small strongyles (Borgsteede et al., 1997, 
Kuzmina et al., 2002). 
Horse strongylids are known to be resistant to Benzimidazoles (BZ) and 
tetrahydropyrimidines (Kaplan, 2002, 2004), while the only case of resistance in 
cyathostomins to microcyclic lactones was reported in donkey in the UK 
(Trawford et al., 2005). 
1.2 Ivermectin 
           Ivermectin was the first macrocyclic lactone anthelmintic, introduced as 
a veterinary anti-parasitic agent in France in 1981 and marketed as a mixture of 
22, 23 dihydro- B1a (>80%) and 22, 23 dihydro- B1b (<20%) (Fisher and 
Morzik, 1989). 
           Ivermectin is today elixir in the world of parasites chemotherapy, it is a 
potent agent, active against many internal and external parasites in domestic 
animals, and it is vogue and highly effective with a wide margin of activity and 
safety. In equines, a variety of adverse reactions have been reported in horses 
after parenteral administration of Ivermectin at the recommended dosage of 
200µg/kg body weight (Reed, 1983). These reactions have occurred in a small 
percentage of treated horses and the drug is now sold as a paste for oral 
administration. Ivermectin have an excellent efficacy for an important range of 
gastro-intestinal nematodes of equine (Campbell et al., 1989). 
1.2.1 Efficacy of Ivermectin against equine endoparasites: 
 Draschia spp and Habronema spp 
Three species, H. musca, H. microstoma and D. megastoma, occur in the 
stomach of equine. The largest one is the H. microstom. The first 2 are free in 
the host’s stomach; D. megastoma lives in nodules in the stomach wall. 
Diagnosis of Habronemiasis is often impossible because the larvae can seldom 
be found in the faeces (Hall, 1985). 
           In horse, Herd and Donham (1984), showed 1-2 intramuscular doses of 
ivermectin at 200 µg/kg were highly effective against Draschia spp and 
Habronema spp., while DiPietro (1982) reported 100% efficacy. 
Gasterophilus spp 
          The larvae of several species of this genus are parasites of equines and are 
known as bots fly, the third- stage larvae causes inflammation and ulceration of 
the mucous membrane of the stomach and duodenum in addition to blood 
sucking (Soulsby, 1982; Hall, 1985). 
 At dose rate of 200-300 µg/kg when Ivermectin given intramuscularly to 
horses, the efficacy was 99% against larvae of Gasterophilus spp, the few larvae 
in the treated horses were located in the large intestine contents and were not 
attached to the intestinal epithelium (DiPietro, 1982).  
Parascaris equorum 
           This is found in the small intestine of horse kind. The infection and 
migration is through the blood stream via the right ventricle of the heart to the 
lungs (Hall, 1985). 
            When given orally as paste formulation, Ivermectin at 200 µg/kg totally 
eliminated the passage of P. equorum in the natural infected horses (Cobra et 
al., 1986). Ivermectin is also active against immature stages of P. equorum, in 
ponies, larval burdens were determined at necropsy following treatment with 
the paste at 200 µg/kg. When necropsy was performed 2 weeks after treatment, 
the reduction in lung larvae burden was 100% (French et al., 1988) and the 
reduction in intestinal larvae burden was also 100 % (DiPietro et al., 1987). 
 Both the paste and the liquid Ivermectin formulations have been shown to 
be highly active against both the early (L3) tissue phase of P. equorum and 
against the later intestinal (L4) phase of P. equorum.  The efficacy has been 
discussed by Boraski (1987).  
Strongloides westeri 
This is occurs in the small intestine, mainly in the duodenum and jejunum 
which causes irritation, resulting in diarrhea, especially in young foals. 200 
µg/kg of Ivermectin was effective against S. westeri in foals in a paste 
formulation (Ryan and Best 1985). 
 Trichostrongylus axei 
A small worm (3-8mm) found in the stomach and duodenum of horse 
kind. In horses T. axie causes chronic catarrhal gastritis (Hall, 1985).      
Stongylus spp 
There are three species, Strongylus equinus, S. vulgaris and S. edentatus 
occur in the large intestine including the caecum of equines (Soulsby, 1982). 
Generally strongylidae worms are not severe pathogens, unless they occur in 
large numbers when their mouth parts cause extensive damage by sucking in the 
mucous membrane, thus causing ulcers. Larvae, however, in the characteristic 
nodules, produced damage, which result in bacterial invasion and consequently 
ulcers. When larvae leave the nodules there is extensive bleeding (Hall, 1985).      
Fourth-stage larvae S. vulgaris penetrate the intima of the sub-mucosal 
arterioles and migrate in the vessels towards the cranial mesenteric artery they 
are to be found here from 14 days after infection onwards associated with 
thrombi and later aneurysms (Soulsby, 1982).  The oral paste and injectable 
formulations of Ivermectin at 200 µg/kg was 100% effective against 8-week-old 
Stongylus vulgaris, as revealed by necropsy 5 weeks after treatment (Klei et al., 
1984). Also as intramuscular injectable formulation at dose rate 200 µg/kg body 
weight Seri and his colleagues (2005) showed that efficacy of Ivermectin 
against arterial stages of Strongylus vulgaris was only 69, 23%. 
Small Strongyles 
            Known as Cyathostomes worldwide, they occur in the large intestine of 
the equides all over the world (Soulsby 1982). Burrows and his colleagues 
(1985) used faecal examination to demonstrate the efficacy of Ivermectin paste 
formulation at 200 µg/kg against benzimidazole-resistant small Strongylus, the 
egg counts remained zero at least 3 weeks in horses. Also 200-300 µg/kg were 
effective against Cyathostomes in percentage of 99% and the efficacy was 86%-
97% against immature stages of Cyathostomes according to 200-300 µg/kg dose 
rate respectively (DiPietro 1982). 
Oxyuris equi 
            A worm lives in the large intestine of horses; males are about 9 – 12 mm 
and females up to 150 mm. According to Seri et al., (2005) the efficacy of 
Ivermectin injectable formulation at dose of 200 µg/kg was 100%. 
1.3 Prevalence of gastro- intestinal nematodes in donkeys and horses 
 Horses, ponies and donkeys are hosts to a large population of parasites 
(Duncan, 1983). Helminths parasite infection was the main problem reported in 
donkeys admitted to veterinary clinic (Ali et al., 2001). 
Swedish nationwide study showed that strongyle infections were highly 
prevalent in Swedish horse herds: 78% of 1183 examined horses on 110 farms 
were found to shed nematode eggs (Lind, 2005). 
In Ethiopia, All of 338 samples examined were found positive for 
helminth eggs. Strongyle spp. (100%), Parascaris equorum (50%) and Oxuris 
equi (3%). 81.7% of donkeys sampled were severely infected, 8.3% heavily, 
3.8% moderately and 6.2% mildly (Ayele et al., 2006). 
In Chad, Garber (1970) reported prevalence of 89% for Strongyle spp. 
and Cyathostomes spp. 72% for Parascaris equorum, and 6% for Strongloides 
westeri. In Kenya, Strongyle spp. prevalence was 57.6%, Cyathostomes spp. 
was 15.4% and 20.7% reported for Parascaris equorum (Mukhwana, 1994). In 
Morocco, the prevalence of different gastro-intestinal nematodes species 
reported as follow: Cyathostomes spp. 52%, Parascaris equorum 37% and 
93.5% was for Trichuris spp. (Abdelkarim, 1991). 
In Sudan, Seri and his colleagues (2004) reported that, the prevalence of 
nematodes infection was 70.1% in Khartoum state, Strongylus spp. 35.8%, 
Cyathostomes spp 36.7% Parascais equrum 10.7%, Trichostrongylus axei 12% 
Strongloides westeri 3.4%.  
 Kheir and Kheir (1981) conducted a field survey in South Darfur State, 
and stated that the overall prevalence was 56.2% and overall incidence of 
infection with nematode parasites was found (58%) in town animals and (22%) 
in nomadic areas. Also five nematode genera were encountered in donkeys in 
the same area: Strongylus spp 43.6%, Oxyuris spp 10.5%, Strongyloides spp. 
3.9%, Parascaris eqourum 4.4% and Trichuris spp. 0.9%. In addition to 
donkeys in south Darfur state, prevalence of gastrointestinal nematodes in 
horses in Bahr Al Arab area was 18.5%. 
 Another study in Sennar state revealed that out of the 218 donkeys 
examined for the parasitic infestation, 193 donkeys were positive and the 
prevalence was 88.53%, the prevalence of Strongylus spp was 100% Oxyuris 
spp. was 0.5%, both highly and moderately infested animals noted 36.27% and 
27.46% for slightly infection (El Dirdiri et al., 1986). 
Recently by postmortem examination, Ahmed (2008) reported that 97.8% 
of examined donkeys at Nyala town were infected with one ore more of gastro-
intestinal parasite. He found that the distribution recovered parasites from 
different parts of GIT were as follows: Stomach (92%) Small intestine (19.6%) 
Caecum (88%) Colon (80%) and Rectum (73.9%). The author reported the 
occurrence of Habronema SPP (40%), Trichostrongylus  axei (30%), G. 
Intestinales (92%), G. Nasalis (77%), Parascaris equorum (18%), 
Anaplocephala perfoliata (4.4%), Gastrodiscus aegyptacus (8.7), Large 
Strongyles (84%) and Small Strongyles (65%).  
  
 
CHAPTER TWO 
Chapter two 
Materials and Methods 
2.1. Survey of gastro-intestinal helminths in donkeys and horses 
A field survey was conducted to study the prevalence of helminth 
parasites in donkeys (Equus asinus) and horses (Equus cabalus). The current 
study was conducted to spot light on the prevalence and intensity of infection 
with gastro-intestinal helminth parasites in South Darfur State during the period 
October 2006 to September 2007. 
2.1.1 Study area 
The study was conducted in South Darfur State which is located in 
western Sudan between latitudes 9º- 30º N and longitudes 13º-15º E (Figure 
2.1). Faecal samples were collected from donkeys and horses from different 
locations in South Darfur State.  
2.1.2 Sample collection and examination 
A total number of 1256 animals (446 horses and 810 donkeys) were 
sampled for fresh faecal samples, fresh faecal samples were collected directly 
from the recta of individual donkeys and horses in long plastic bags, after 
labeling of the bags, the samples were submitted as soon as possible to the 
diagnostic laboratory of the Veterinary Research laboratory, Ministry of 
Sciences and Technology in Nyala. Egg count was done using modified 
McMaster technique (Anonymous, 1986) and the eggs were identified 
according to Soulsby (1982).  
2.1.3 Intensity of infection 
The severity of the infection was obtained from the number of egg per 
gram of faeces and was classified according to Soulsby (1982) as follows:  
             500 egg per gram of faeces ? Mild infection 
 
 Figure 2.1 Map of South Darfur state, Sudan. 
              800-1000 egg per gram of faeces ?Moderate infection 
             1500-2000 egg per gram of faeces ? severe infection 
2.1.4 Parasitological techniques  
2.1.4.1 The modified McMaster technique  
A modified McMaster technique (Anonymous, 1986) was used to count 
the egg per gram (epg) of faeces as following:  
1. Three grams of faeces were mixed with 42 ml of tap water and the faecal 
suspension was passed through the 80 µm square sieve to remove debris. 
2.  The filtrate was collected in a clean dry container.  
3. 15 ml of this filtrate was taken into a centrifuge tube and centrifuged at 
1500 rpm for 2 minutes and the supernatant was then discarded. 
4. The sediment was emulsified by gentle agitation and saturated Na Cl was 
added until the volume became equal to the initial aliquot of the filtrate. 
5. The centrifuged tube was inverted several times to obtain an even 
suspension of the contents. 
6. The two chambers of the McMaster slide were filled using a clean Pasteur 
pipette. 
7. The average number of eggs present in the chambers was multiplied by 
100 to obtain the number of egg per gram of faeces (epg). 
2.1.4.2 Faecal culture and identification of larvae 
A pooled culture of positive faecal samples was examined for larval 
identification, and where possible 100 third stage larvae were identified as 
described by Anonymous (1986). 
2.2 Therapeutic efficacy of Albendazole against donkey’s worm infestation 
The aim of this study was to investigate the therapeutic efficacy of 
Albendazole at two different dose regimens as an anthelmintic in donkeys 
harbouring natural worm infestation and to compare the results obtained with 
that of Ivermectin. 
2.2.1 Experimental Animals 
         In this study we utilized 24 male donkeys (3-10 years). Before starting the 
study, animals were examined to prove infestation with gastrointestinal 
helminth parasites. Animals were kept in the premises of the Department of 
Clinical Studies, Faculty of Veterinary Science, and University of Nyala (Figure 
2.2). They were provided with tap water and allowed to graze in pasture freely.  
2.2.2 Experimental drugs 
Albendazole suspension:  Albendex 25mg/ml (Avico®. Jordon).  
Ivermectin drench: Avimec liquid (Avico®. Jordon)  
2.2.3 Design of the study  
           Experimental animals were allocated into four groups and penned 
according to treatment groups. The first three groups were treated and the last 
group was remained untreated as control group. 
            The animals in the three treatment groups received treatment as follows: 
- Albendazole – treated group 1 (ABZT1) received a single oral dose of 
Albendazole at the manufacturer recommended dose i-e 10 mg/kg body weight. 
- Albendazole – treated group 2 (ABZT2) received two oral doses of 
Albendazole 14 days apart, at the manufacturer recommended dose i-e 10 
mg/kg body weight. 
- Ivermectin treated group (IVMT) received a single oral dose of Ivermectin 
drench at the manufacturer recommended dose i-e 200 µg/kg body weight.  
          Then donkeys were monitored for possible adverse reactions for 2 hours 
after administration of each drug. 
2.2.4. Sampling and Time schedule 
          The experiment extended for 21 days. Faecal samples were collected at 0 
(before treatment), 1, 3, 7, 14, and 21 days post treatment. Necropsy of the 
animals was done at day 21 post treatment for all donkeys. 
  
 
 
 
 
 
 
Figure 2.2 Experimental animals allocated and penned in the clinic of 
Faculty Veterinary Sciences, Nyala University. 
2.2.5 Necropsy of animals and samples preparation 
Animals were euthanized for worm recovery as described by Reinecke 
and Le Roux (1972). After donkeys were euthanized as shown in figures (2.3-
2.7). The thoracic and abdominal cavities were opened by making an incision 
along the ventral line of the animal and the left half of the thorax and the 
abdominal wall was removed. The organs from the thoracic and the abdominal 
cavities were removed from the carcass. The different organs from the gastro-
intestinal tract were then isolated by tying double ligatures around the gut to 
separate it in the stomach, small intestine, caecum, colon and rectum. The 
contents of the different organs were removed and then sieved through 150 mm 
sieve to obtain residue samples. The residues preserved in 10% formalin. 
Residue samples of ingesta were examined macroscopically.  Nematodes 
present were placed in a specimen bottle containing 10% formalin. Helminths 
were identified at a later stage by placing them on glass slide, examining them 
microscopically and classifying them according to Lichtenfels (1975). 
2.2.6 Data analysis 
The anthelmintic efficacy of Albendazole was estimated using faecal egg 
count reduction test (FECR) for helminths burden. Arithmetic mean of the egg 
counts and helminths burden were calculated to determine the mean percentage 
reduction within each group, according to the following formula: 
 FECR % = Pre-treatment EPG - Post-treatment EPG X 100 
                                      Pre-treatment EPG  
2.3 An assay of some biochemical parameters in donkeys medicated with 
benzimidazole: 
2.3.1 Collection of samples: 
Blood samples were collected from the jugular vein of each animal and 
were allowed to clot for 24 hours then the sera harvested and freezed for 
serological tests.   
 
  
 
 
 
 
 
 
Figure 2.3 Preparation and control of a donkey for Euthanasia. 
  
 
 
 
 
 
Figure2.4 bleeding of a donkey from the group treated with Albendazole. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.5 Abdominal cavity of Euthanized donkey treated with 
Albendazole. 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.6 Cranial mesenteric artery removed from euthanized donkey 
treated with albendazole. 
  
 
 
 
Figure 2.7 Stomach removed from euthanized donkey treated with 
Albendazole 
2.3.2 Biochemical methods 
2.3.2.1 Total Serum Protein (TSP)  
The Biuret method as described by King and Wooton (1956) was utilized 
to assess TSP using commercial kits (Spectrum, Egypt).  
Principle of the test 
In alkaline medium the copper reacts with the peptide bonds of protein to 
form the characteristic pink to purple biuret complex. Sodium potassium 
tartarate prevent copper hydroxide precipitation and potassium iodide prevents 
the auto-reduction of copper. The colour intensity is directly proportional to the 
protein concentration. The change in colour was measured using 
spectrophotometer (Jenway 6105 U.V./vis. Spectrophotometer, U.K.). 
2.3.2.2 Serum Albumin 
Concentration of serum albumin was measured by Bromocresol green 
method according to Bartholomew and Delany (1966). 
Principle of the test 
Measurement of serum Albumin based on its binding to the indicator dye 
bromochresol green (BCG) in pH 4.3 to form a blue-green coloured complex. 
The intensity of the blue-green colour is directly proportional to the 
concentration of albumin in the sample. The assay was conducted using 
commercial kits (Spectrum, Egypt). 
2.3.2.3 Serum Urea 
Urea is the major end product of protein nitrogen metabolism. It is 
synthesized by the urea cycle in the liver and excreted through the kidneys. The 
circulating levels of the urea depend upon protein intake, protein catabolism and 
kidneys function. Elevated urea level can occur due to renal impairment or in 
some diseases such as diabetes, infection, congestive heart failure, and during 
different liver diseases. Determination of blood urea nitrogen is most widely 
used screening test for renal function together with serum creatinine.  
The principle of the test 
Urea is hydrolyzed in the presence of water and urease to produce: 
Urea + H2O     urease    ›   2NH3 + CO2 
 The free ammonia in an alkaline pH and in the presence of the indicator 
forms coloured complex proportional to the urea concentration (mg/dl) in the 
specimen. 
 Serum urea concentration was measured by an enzymatic colorimetric 
method using a commercial kit (Randox laboratories Ltd., United Kingdom) 
according to Fawcett and Scott (1960). The intensity of the developing colour 
was measured at 600 nm using Jenway spectrophotometer (Jenway 6105 U. V. 
/vis. Spectrophotometer, U. K.). 
2.3.2.4 Serum creatinine  
Creatinine is derived from creatine and the creative phosphate in the 
muscle tissue, and may be defined as a nitrogenous waste product. Creatinine is 
not reutilized but it is excreted from the body through the urine via the kidneys.  
Principle 
Creatinine reacts with picric acid under alkaline condition to form a 
yellow-red complex. The intensity of the developing colour was measured at 
wavelength 492nm, using Jenway spectrophotometer (Jenway 6105 U. V. /vis. 
Spectrophotometer, U. K) according to Bartels et al., (1972).The commercial 
kits used were also from the same manufacturer (Spectrum, Egypt). 
2.3.2.5 Serum Calcium  
Calcium is the fifth most common element in the body, most of which 
(98%) is present in the skeleton. One half of the remaining calcium is found in 
extracellular fluid and the rest in tissue. Calcium has a crucial role in bone 
mineralization and is also vital for basic physiological processes such as blood 
coagulation, neuromuscular conduction, and normal muscle tone. 
The principle of the test 
Calcium ions react with O-cresolphthalein complexone (O-CPC) under 
alkaline condition to form violet coloured complex. The colour intensity of the 
complex formed is directly proportional to the calcium concentration (mg/dl). It 
is determined by measuring the increase in absorbance at 578nm using 
commercial kit (Spectrum, Egypt). The calcium values were calculated in 
mmol/l of serum according to Sarkar and Chauhan (1967) and Barnett et al., 
(1973). 
2.3.2.6 Serum inorganic phosphorus  
The body contains phosphorus entirely in the form of phosphates 
distributed fairly equally between extracellular and intracellular compartments. 
About 85% of extracellular phosphate occurs in inorganic forms as 
hydroxyapatite. In plasma or serum, most phosphate exists in the inorganic 
form; this fraction is present as the mono- and dihydrogen forms. The relative 
proportion is varying with the pH. Intracellular phosphate occurs mainly in as 
phospholipids and phosphoproteins; this fraction is termed organic phosphate. 
Assay principle 
         Inorganic phosphate reacts with ammonium molybdate in sulphuric acid to 
form no reduced phosphomolbdate. The concentration of phosphomolbdate 
formed is directly proportional to the inorganic phosphate concentration. It is 
determined by measuring the increase in absorbance at 340 nm.  The serum 
inorganic phosphorus was determined according to Taussky and Shorr (1953) 
and Goldenburg and Fernandez, (1966). 
2.4. Statistical Methods 
SPSS 11.5 for windows computer package was utilized to assess 
significant differences, if any. Paired T-test was used to compare between 
means. 
 
  
 
 
CHAPTER THREE 
Chapter three 
Results 
3.1 Survey of gastro-intestinal nematodes in donkeys and horses: 
In the current study a total of 1256 donkeys and horses were examined 
for helminth gastrointestinal nematodes, during the period October 2006 to 
September 2007. The overall prevalence of infection with gastro-intestinal 
nematodes in equines was 29.20% (Table 3.1). During the survey period, 
November showed the highest incidence of infection (41.50%), while June 
showed the lowest percentage 13.92% (Figure 3.2). 
Considering severity of infection, animals with mild infection were 
dominant (81.35%), while animals with severe infection were 10.54%, and 
animals with moderate infection were the lowest one 8.11% (Table 3.3). The 
highest incidence of mild infection was reported in August (93.75%) and the 
lowest incidence was on April 64.29%. In animals harbouring moderate 
infection, the lowest infection level was 0% and reported in August and the 
highest moderate infection level was reported in March 20.69%. Severe 
infection reported 0% in the lowest incidence level in June while 28.57% in 
April as the highest (Table 3.3). 
            The results of faecal culture and identification of larvae revealed the 
dominance of following helminth genera: Strongylus spp, Cyathostomum spp, 
Trichostrongylus spp, and Strongyloides westeri. No efforts to larvae count had 
done. 
In this study, a total of 443 horses were involved in the current survey. 
The prevalence of infection was 15.35% (Table 3.5). March reported the lowest 
prevalence level of 5.26% and in November was the highest one 50% (Table 
3.5). In February we failed to examine any horse. A total number of 810 
donkeys were involved in this study. The prevalence of infection was 37.48%. 
The highest prevalence infection was reported in January 55.79% and the lowest 
one was 14.89% reported in May (Table 3.5). 
  
             
  Table 3.1 overall prevalence of gastrointestinal nematodes in donkeys and 
horses in South Darfur State 
 
Type Total number Infected animals Prevalence%
Horses 446 68 15.73 
Donkeys 810 302 37.48 
Total 1256 370 29.78 
Mean per month 104.42 30.83 29.20 
 
 
  
 
 
 
 
 
Figure 3.1Percentage of donkeys to horses in the population sampled. 
 
 
 
  
 
 
 
Figure 3.2 Prevalence of gastro-intestinal nematodes in donkeys and horses 
per month 
  
Table 3.2 Mean± SD and range of egg per gram of faeces (epg) in donkeys 
and horses infested with gastro-intestinal nematodes 
Month Mean ± SD Range 
January 400.86 ± 640.41 50-3800 
February 890.91±1,231.63 50-4500 
March 655.17 ±859.65 50-3600 
April 1390.03 ±2401.26 50-11800 
May 457.89 ±526.32 50-1700 
June 290.00± 242.44 50-900 
July 283.75 ±290.53 50-1600 
August 340.00± 364.10 50-1500 
September 565.71 ±1366.55 50-8000 
October 889.29 ±1,641.45 50-10400 
November 608.49 ±1,725.63 50-13450 
December 307.58 ±542.29 50-2400 
Total 589.97 ±986.02 50-13450 
 
 
               
  
               Table 3.3 Severity of infection with gastro-intestinal nematodes in 
donkeys and horses per month 
 
Month Mild% Moderate% Severe% 
January 87.93 3.45 8.62 
February 72.73 18.18 9.09 
March 68.97 20.69 10.34 
April 64.29 7.14 28.57 
May 84.21 5.26 10.53 
June 81.82 18.18 0 
July 92.68 4.88 2.44 
August 93.75 0 6.25 
September 77.14 5.71 17.14 
October 67.86 10.71 21.43 
November 88.52 4.92 6.56 
December 78.79 15.15 6.06 
Total  81.35 8.11 10.54 
 
 
 
  
 
 
 
 
 
Figure 3.3 Severity of infection with gastro-intestinal nematodes in donkeys 
and horses per month 
   The Mean ± SD for egg per gram of faeces (epg) was 975.37 ± 
1099 for the whole year with a range of 50-13450 (epg). December reported the 
highest mean epg count 2300 ± 0 with a range of 0-2300(epg). July showed 
Mean ± SD of 300±0 of egg per gram of faeces with range of 0-300 (epg) as the 
lowest epg count (Table 3.6). Also in table (3.6) we could observe that the 
Mean ± SD of egg per gram of faeces for the 12 months in donkeys was 
750.14±1071.95 with a range of 50-11800 (epg). The Highest range was 
reported in April 100-11800 (epg) with the highest Mean ± SD in the whole 
year 1888.89±2855.51 (epg). August reported the lowest level 261.54±185.02 
(epg) with a range of 100-700 (Table 3.6). 
            The range of egg per gram of faeces showed several variations in the 
minimum level during the whole year. In February was too high that reported 
300 epg while 200 epg as a minimum epg level was reported twice in both May 
and June respectively.100 epg was reported several times also 50 epg (Table 
3.6). 
Considering severity of infection, in mild infection the highest incidence 
of mild infection was reported in June and July with 100% of the animals 
showing mild level of infection, while no animal was infected on December 
exhibited mild level of infection (Table 3.7). Moderate level infection showed 
8.82% as the highest level was reported in March (33.33%) and 0% was the 
lowest level reported in several months. The highest severe level of infection of 
100% was reported in November and 0% was the lowest level reported several 
months (Table 3.7).               
In donkeys, concerning severity of infection, mild infection was the 
prevalent with a 81.25%, while moderate infection showed 7.89% and 10.86% 
for the severe infection (Table 3.7). The highest mild infection percentage 
reported was 100% in August.  While 55.56% was reported twice as the lowest 
mild level of infection. The moderate level infection generally showed small 
percentage 7.89% when compared to mild and severe infection. The highest 
percentage of moderate infection was reported in June 20%, and the lowest 
moderate infection 0% was reported in August and September respectively. 
Severe infection reported the highest percentage in April 38.89%. Both June 
and August reported 0% as the lowest percentage (Table 3.7). 
 
             
 Table 3.4 Prevalence of gastro-intestinal nematodes in donkeys and horses 
per month 
Prevalence% 
Month 
Horses Donkeys 
January  10.64 55.79 
February  ND 34.38 
March  5.26 46.43 
April  17.86 30.51 
May   20.34 14.89 
June  10.64 15.63 
July  9.09 37.25 
August  10.00 26.00 
September  18.33 24.00 
October   20.83 50.00 
November  50.00 42.11 
December  7.69 48.53 
Total 15.73 37.48 
  
 Table 3.5 Mean± SD and range of egg per gram of faeces (epg) count in 
donkeys and horses infested with gastro-intestinal nematodes per month 
Mean ± SD Range 
Month 
Horses Donkeys Horses Donkeys 
January  340±357.77 402.83± 664.01 50-900 100-3800 
February  ND 890.91± 1,231.63 ND 300-4500 
March  3600±1417.75 603.85±791.19 50-2800 100-3600 
April  405.56±766.56 1888.89± 2855.51 100-3300 100-11800 
May   441.67±529.94 485.71± 561.04 50-1700 200-1700 
June  160±54.77 420.00± 294.96 50-200 200-900 
July  300±0 282.89±298.26 300 50-1600 
August  850±919.24 261.54±185.02 50-1500 100-700 
September  1485±1768.91 1485.00±1,768.91 50-8000 100-8000 
October   1185±1768.91 1335.29± 1822.82 50-10400 50-6250 
November  637.23±1822.82 637.23±1,822.82 50-13450 50-2650 
December  2300±0 307.58±542.29 2300 50-2400 
Total  975.37±1099 750.14±1071.95 50-13450 50-11800 
 
 
Table 3.6 Severity of infection with gastro-intestinal nematodes in donkeys 
and horses per month 
Mild% Moderate% Severe% 
Month Horses Donkeys Horses Donkeys Horses Donkeys 
January  80.00 88.68 20.00 1.89 0 9.43 
February  ND 75.00 ND 16.67 ND 8.33 
March  33.33 73.08 33.33 19.23 33.33 7.69 
April  90.00 55.56 0 5.56 10.00 38.89 
May   83.33 85.71 8.33 - 8.33 14.29 
June  100.00 80.00 0 20.00 0 - 
July  100.00 94.74 0 2.63 0 2.63 
August  50.00 100.00 0 - 50.00 - 
September  81.82 75.00 18.18 - 0 25.00 
October   90.00 55.56 0 16.67 10.00 27.78 
November  85.71 85.71 14.29 7.14 0 7.14 
December  0 78.79 0 18.18 100.00 3.03 
Total 82.35 81.25 8.82 7.89 8.82 10.86 
 
 
3.2 Therapeutic efficacy of Albendazole and Ivermectin drench in donkeys 
3.2.1 Egg per gram reduction 
The result of mean egg per gram of faeces and the range in addition to the 
reduction percentage of egg per gram of faeces for the three treated groups from 
day zero to day 21 are presented in tables (3.8, 3.9 and 3.10). 
On day 3, Albendazole showed reduction of 97.13% egg per gram count 
(EPGC), while Albendazole with the two doses showed 98.90%. In Ivermectin 
treated group 98.94% of egg per gram count (EPGC) was reported. 
          All three groups reported 100% reduction of egg per gram of faeces on 
day 7 and till day 21 when animals were euthanized. 
3.2.2 Post-mortem findings 
          The results of post-mortem findings are presented in tables (3.11, 3.12 
and 3.13) for the three groups. Albendazole reported efficacy of 97.13% at the 
single dose while albendazole at the two doses reported 98.90%, but the 
efficacy against L4 Strongylus vulgaris found in cranial mesenteric arteries was 
33% for Albendazole and 59.08 %for Albendazole twice. On the other side, 
Ivermectin reported 62.71% efficacy against L4 Strongylus vulgaris. 
  
 
 
Table 3.7 Mean faecal egg counts (±SD) and reduction percentage for 
Albendazole-treated donkeys 
 
Days 
Arithmetic mean 
(epg) 
Range Reduction% 
0 3621.43±3583.05 500-10400 - 
1 1221.43±1526.94 200-4500 66.27% 
3 21.43±39.34 50-100 98.25% 
7 0 0 100% 
14 0 0 100% 
21 0 0 100% 
 
 
  
 
Table3.8 Mean faecal egg counts (±SD) and reduction percentage for 
Albendazole twice-treated donkeys 
 
Days Arithmetic mean (epg) Range Reduction % 
0 2462.50 ± 2137.50 1300-4500 - 
1 1250.00 ± 574.46 900-2100 49.24% 
3 100.00 ±141.42 0-300 92% 
7 0 0 100% 
14 0 0 100% 
21 0 0 100% 
 
  
 
 
Table 3.9 Mean faecal egg counts (±SD) and reduction percentage for 
Ivermectin-treated donkeys 
 
Days Arithmetic mean (epg) Range Reduction % 
0 783.33 ± 625.03 50-1900 0 
1 1683.33 ± 1586.72 0-3500 -114.89% 
3 16.67 ± 40.82 0-100 99.01% 
7 0 0 100% 
14 0 0 100% 
21 0 0 100% 
 
 Table 3.10 Summary of harvested worms from control and animals treated 
with Albendazole (ABZT1) drench at necropsy. 
Albendazole 
Organs examined Control 
No. Reduction % 
Cranial mesenteric artery 
Strongylus vulgaris 303 203 33.00 
Stomach 
Gasterophilus spp. 349 273 21.78 
Habronema spp. 291 147 49.48 
Trichostrongylus axei 79 26 67.09 
Small Intestine 
Parascaris equorum 25 0 100.00 
Strongloid westeri 31 10 67.74 
Caecum 
Gasterophilus spp. 3151 59 98.13 
Strongylus spp. 841 157 81.33 
Cyathostomes spp. 6012 0 100.00 
Colon and Rectum 
Strongylus spp. 6800 109 98.40 
Cyathostomes spp. 37660 701 98.14 
Oxyuris equi 3151 0 100.00 
 Table 3.11 Summary of harvested worms from control and animals treated 
with Albendazole Twice (ABZT2) drench at necropsy. 
Albendazole Twice 
Organs examined Control 
No. Reduction % 
Cranial mesenteric artery 
Strongylus vulgaris 303 124 59.08 
Stomach 
Gasterophilus spp. 349 393 (12.61) 
Habronema spp. 291 24 91.75 
Trichostrongylus axei 79 0 100.00 
Small Intestine 
Parascaris equorum 25 0 100.00 
Strongloid westeri 31 0 100.00 
Caecum 
Gasterophilus spp. 3151 0 100.00 
Strongylus spp. 841 0 100.00 
Cyathostomes spp. 6012 50 99.17 
Colon and Rectum 
Strongylus spp. 6800 54 99.21 
Cyathostomes spp. 37660 0 100.00 
Oxyuris equi 3151 0 100.00 
Table 3.12 Summary of harvested worms from control and animals treated 
with Ivermectin (IVMT) drench at necropsy. 
 
 
 
Ivermectin 
Organs examined Control 
No. Reduction % 
Cranial mesenteric artery 
Strongylus vulgaris 303 113 62.71 
Stomach 
Gasterophilus spp. 349 0 100.00 
Habronema spp. 291 2 99.31 
Trichostrongylus axei 79 0 100.00 
Small Intestine 
Parascaris equorum 25 0 100.00 
Strongloid westeri 31 0 100.00 
Caecum 
Gasterophilus spp. 3151 0 100.00 
Strongylus spp. 841 10 98.81 
Cyathostomes spp. 6012 0 100.00 
Colon and Rectum 
Strongylus spp. 6800 500 92.65 
Cyathostomes spp. 37660 0 100.00 
Oxyuris equi 3151 0 100.00 
  
 
 
 
   Figure 3.4 The percentage efficacy of Albendazole (Different dose 
regimen) and Ivermectin at 14 days post treatment. 
  
 
 
 
 
Figure 3.5 larvae of Strongylus vulgaris in cranial mesntric artry removed 
form Albendazole treated donkey. 
  
 
 
 
Figure 3.6 larvae of gasterophilus in a stomach removed from Albendazole 
treated donkey. 
  
 
 
 
Figure 3.7 Parascaris equorum removed from small intestine of donkey in 
the control group  
  
 
 
 
Figure 3.8 Parascaris equorum expeled from small intestine of donkey in the 
Ivermectin  Drench treated group on day 3 post treatment. 
  
 
 
 
 
Figure 3.9 lareg and small strongyles in a Caecum removed from donkey in 
the control group 
 
 
 
 
  
 
 
 
Figure 3.10 Encysted larvae of small strongyles in colon of donkey in the 
control group.
3.3 An assay of some biochemical parameters in donkeys (Equus asinus) 
medicated with Albendazole: 
          As shown in table (3.13) there was no significant (P>0.05) difference in 
the three treated groups in total protein concentration following administration 
of the experimental anthelmintics through out the whole experiment period (21 
days). 
           In table (3.14) we could observe that there is significant (P<0.05) 
increase in albumin concentration 24 hours following treatment with Ivermectin 
when compared with day zero. While animals in the other two treatment groups 
exhibited only fluctuation in albumin concentration.  
As we could observe in table (3.15) there is no significant difference in 
the treated groups during the whole experiment period in urea concentration.  
As shown in table (3.20) animals treated with albendazole at two doses 
14 days apart showed significant decrease in creatinine concentration in days 3 
and 7 following administration of albendazole and the decrease although non-
significant remained to the end of the experiment. 
          Serum Calcium and serum inorganic-phosphorus results obtained were 
presented in tables (3.17) and (3.18), respectively. Serum Calcium, in 
Albendazole treatment groups showed significant increase in days 1, 3 and 14 in 
animals treated with one dose, and in days 7 and 14 following treatment with 
albendazole at two doses 14 days apart.  
In animals treated with two doses of albendazole, inorganic phosphorus 
showed significant increase 14 days following treatment. 
 Table 3.13 Changes in total protein concentration (g/dL) following oral 
administration of experimental anthelmintics compounds  
 
ABZT1 ABZT2 IVMT 
DAY 
Mean ± SD  Mean ± SD  Mean ± SD 
0 09.94±2.24 08.47±0.88 8.02±1.22 
1 09.06±1.50 09.64±1.24 8.76±0.73 
3 10.96±2.56 12.52±5.55 8.49±0.70 
7 08.53±0.73 10.30±0.95 8.56±0.84 
14 08.21±0.33 08.97±0.58 8.02±0.51 
21 09.53±0.39 10.74±1.87 8.86±0.72 
 
 
 
 
 
 
 
 
 
Table 3.14 Changes in albumin concentration (g/dL) following oral 
administration of experimental anthelmintics compounds 
 
ABZT1 ABZT2 IVMT 
DAY 
Mean ± SD  Mean ± SD  Mean ± SD 
0 3.14±0.36 2.88±0.44 2.88±0.44 
1 3.15±0.33 3.25±0.37 3.88±0.43* 
3 3.06±0.36 3.18±0.42 2.91±0.41 
7 2.95±0.59 3.84±0.66 3.74±0.81 
14 2.95±0.50 3.28±0.28 2.73±0.33 
21 3.16±0.21 3.66±0.86 3.19±0.57 
 
(*) Means on the same column have asterisk are significantly different with day 
zero  
  
Table 3.15 Changes in urea concentration (mg/dL) following oral 
administration of experimental anthelmintics compounds 
 
ABZT1 ABZT2 IVMT 
DAY 
Mean ± SD  Mean ± SD  Mean ± SD 
0 8.57±1.61 09.26±1.94 7.47±1.37 
1 7.01±0.35 09.16±3.14 7.10±0.73 
3 7.60±1.18 09.19±3.28 8.14±0.82 
7 7.68±1.13 11.57±3.86 8.41±1.01 
14 8.12±3.80 06.89±2.14 7.57±1.42 
21 9.71±2.82 09.55±2.72 8.35±2.12 
 
 Table 3.16 Changes in creatinine concentration (mg/dL) following oral 
administration of experimental anthelmintics compounds 
 
ABZT1 ABZT2 IVMT 
DAY 
Mean ± SD  Mean ± SD  Mean ± SD 
0 0.89±0.18 1.10±0.16 0.86±0.13 
1 0.95±0.24 0.89±0.25 0.83±0.14 
3 0.73±0.12 0.55±0.35* 0.88±0.02 
7 0.85±0.05 0.35±0.28* 0.96±0.07 
14 0.93±0.12 0.74±0.37 0.81±0.18 
21 1.26±0.80 0.55±0.65 0.82±0.33 
 
 
(*) Means on the same column have asterisk are significantly different with day 
zero  
 Table 3.17 Changes in calcium concentration due (mg/dL) following oral 
administration of experimental anthelmintic compounds 
 
ABZT1 ABZT2 IVMT 
DAY 
Mean ± SD  Mean ± SD  Mean ± SD 
0 08.21±0.75 08.19±1.23 08.54±0.96 
1 10.34±1.01* 09.22±1.01 09.75±1.68 
3 11.43±1.35* 09.94±1.59 10.16±1.83 
7 09.18±1.58 11.21±1.09* 10.25±1.89 
14 09.78±0.89* 11.36±1.14* 09.81±1.64 
21 09.81±2.85 09.82±1.00 08.82±0.95 
 
(*) Means on the same column have asterisk are significantly different with day 
zero  
  
Table 3.18 Changes in inorganic-phosphorus concentration (mg/dl) 
following oral administration of experimental anthelmintics compounds 
 
ABZT1 ABZT2 IVMT 
DAY 
Mean ± SD Mean ± SD  Mean ± SD 
0 4.63±2.57 3.81±1.79 3.90±0.84 
1 5.18±1.58 5.75±2.53 4.11±1.26 
3 7.26±2.97 7.58±3.99 5.79±1.56 
7 6.59±2.10 9.34±5.47 5.74±3.38 
14 4.79±0.71 6.46±0.74* 5.30±2.35 
21 5.39±1.87 9.66±5.24 5.60±1.18 
 
(*) Means on the same column have asterisk are significantly different with day 
zero . 
  
 
CHAPTER FOUR 
Chapter four 
Discussion 
From the results obtained in this study, it is interesting to note that, the 
overall prevalence for both donkeys and horses with CIT parasited was found to 
be 29.785%, this is in harmony with the results obtained by Kheir and Kheir 
(1981) in Bahr El Arab (22%), while it is less than that reported in Nyala town 
(58%), this may be referred to the large number of animal examined in this 
study (1256 animal) when compared to Kheir and Kheir (390 animals), and also 
to the availability of anthelmintics compounds. In Sennar-Sudan also El Dirdiri 
et al., (1986) reported a similar percentage of infection with gastro intestinal 
diseases (27%).  
Prevalence of gastrointestinal nematodes in horses noticed in this study 
was 15.73%, which is in close agreement with that reported by Kheir and Kheir 
(1981) in Bahr El Arab (18.5%).  Results obtained in this study concerning the 
prevalence of helminth nematodes in donkeys was 37.84% this result is very 
low when compared with that reported by Seri et al., (2004) in Khartoum state-
Sudan (70.1%), while Kheir and Kheir (1981) reported that the overall 
incidence of infection with nematode parasites was found higher in town 
animals (58%) than in animals kept in nomadic areas (22%). 
The overall Mean ± SD for egg per gram of faeces (epg) was 589.97 ± 
986.02 and the range was 50-11800 (epg), this is low when compared with Seri 
et al., (2004) (1016.6 ± 363.6) (epg), this may be attributed to the large 
percentage of mild infection obtained in this study (81.35%) when compared to 
that of Seri et al., (2004) who reported 58.6% in donkeys examined in 
Khartoum state. 
The highest Mean ± SD was observed in April (hot season) 1390.03 ± 
2401.26 with a range of 50-11800 (epg), and the lowest was in June (rainy 
season) 290.00 ± 242.44 with a range of 50-900 (epg). 
Concerning severity of infection reported in this study, 81.35% for mild 
infection, both moderate and severe burdens shared the lower incidence (8.11% 
and10.54% respectively) these findings are in agreement with Seri et al., (2004) 
in donkeys (58.6%, 21.9% 19.5%) for mild, moderate and severe infections 
respectively. 
However, all the findings obtained in the survey during the whole year 
were affected with the extensive miss-use of anthelmintics by animal’s owners 
in absence of veterinary authorities where sometimes sub doses, over dosage of 
anthelmintics, wrong timing of de-worming and a lot of misconceptions of de-
worming were applied, what shows apparent differences in the results in this 
study.  
Therapeutic efficacy of Albendazole in donkeys in this study, in both 
groups of animals treated with either single dose or two doses of Albendazole at 
10 mg/kg were resulted in 100% reduction in (epg) count on day 7 post 
treatment. Kuzmina and Kharchenko (2008) obtained a similar result at day10 
post treatment in horses treated with a dose rate of 5mg/kg body weight in 
Ukraine to control Strongylus spp. 
         Following post-mortem, Albendazole administered at single dose resulted 
in low efficacy of 49.48% against Habronema sp., and Trichostrongylus axei 
67.09%, Strongyloid westeri 67.74%;  but expressed high efficacy against 
Parascaris equorum100%; and 81.33%, 98.40% for Strongylus spp. Present in 
caecum, colon and rectum respectively; Cyathostomes spp 100% 98.14% for 
caecum, colon and rectum respectively. This result explained by the 
justification of Gokbulut et al., (2005) who stated that, a higher metabolic 
capacity, first-pass effect and lower absorption of benzimidazoles in donkeys 
decrease bioavailability and efficacy compared to ruminants, this explanation 
also justify the increase in efficacy when we used the double dose for the 
second group in this study   
             Albendazole at single and multiple dose regimen showed efficacy of 
21.78% and (12.61)% against Gasterophilus spp. Albendazole at two doses 14 
days apart showed the following  efficacy percentages against: Habronema spp. 
91.75%; Trichostrongylus axei100.%; Parascaris equorum 100% , Strongloid 
westeri 100% ; Strongylus spp .in the caecum,  colon and rectum 100%, 99.21% 
respectively. Cyathostomes spp in the caecum, colon and rectum 99.17% and 
100% respectively; and 100% for Oxyuris equi. These results are in agreement 
with that obtained by Kuzmina and Kharchenko (2008) in Ukraine. Besides the 
strongylid nematodes, eggs of Parascaris equorum, Oxuyris equi, Strongyloides 
westeri and Habronema spp. were found in faecal samples a day before 
treatment. No eggs of these nematodes were found in horse faeces on the 10th 
and 14th days after treatment with the both drugs. 
In this study, Ivermectin showed 100% faecal egg count reduction on day 
7 this is in agreement with Seri et al., (2005) who reported the same result when 
used  ivermectin injectable formulation intramusclarlly at dose rate of 200µg/kg 
body weight in donkeys in sudan, the efficacy against Habronema spp was 
99.31% this result is in close agreement with that reported in horse by Herd and 
Donham (1984), who showed 1-2 intramuscular doses of Ivermectin at 200 
µg/kg were highly effective against Draschia spp and Habronema spp., while 
DiPietro (1982) revealed 100% efficacy. When Ivermectin given 
intramuscularly to donkeys at dose rate of 200 µg/kg, the efficacy was 100% 
against larvae of Gasterophilus spp. (Seri et al., 2005), this result is in 
agreement with the results (100%)  obtained in this study. Ivermectin 
successfully (100%) removed P. equorum from the small intestine when given 
orally as paste formulation at 200 µg/kg. Ivermectin totally eliminated the 
passage of P. equorum in the natural infected horses (Cobra et al., 1986). In 
case of T. axie Ivermectin (100%) eliminated T. axie from the small intestine of 
donkeys this also the same condition when used at dose rate of 200 µg/kg in 
intramuscular formulation (Seri et al., 2005). In this study, Strongylus spp were 
98.81% eliminated from caecum and 92.65% from the colon and rectum, which 
is in close agreement when compared with that reported by Seri et al., 
(2005)100% when they used Ivermectin injectable formulation intramuscularly 
for donkeys at dose rat of 200 µg/kg, a result which may be attributed to the 
route of administration that affects the bioavailability of the drug in this study. 
 Cyathostomes spp were 100% eliminated from both caecum and colon in 
this study, this result also is in agreement with that obtained by Seri et al., 
(2005). Costa et al., (1998) when utilized Ivermectin at same dose rate of 200 
µg/kg for equine in Brazil as a paste formulation reported an efficacy of 100% 
against Oxiuris equi, the same result was also obtained in this study. In this 
study, Ivermectin expressed moderate efficacy against Strongylus vulgaris 
larvae which found in the cranial mesenteric arteries 62.71% this result is to be 
considered in the same range with that reported by Costa et al., (1998) and Seri 
et al., (2005) and the results were 67.8%, 69,23% respectively. 
         In this study, the values obtained for the total protein values in the three 
treatment groups were higher than reference values obtained by other 
researchers worldwide and not in harmony with the values reported by Zinkl et 
al., (1990) 7.2±0.7 in American donkeys and that 6.82 ±0.40 reported by Mori 
et al., (2003) in Brazilian donkeys, we attribute this difference to the breed 
and/or the technical method used. Daly and Hogan (1982) reported increasing of 
urinary protein in rats treated with albendazole at 30 and 45 mg/kg bw (3 and 
4.5 times of recommended dose, respectively). 
           In the current study,  Albumin concentration fluctuated within the normal 
level for albendazole treated groups which ranged between 2.88±0.44 g/L on 
day 0 for Albendazole treated group 1 to 3.66±0.86 g/L on day 21 for the 
animals treated with two doses with non significant differences, and this is on 
line with reference range 3.48 ± 0.148 reported in India by Gupta (1994) and 
not in harmony with Daly and Hogan (1982), who reported increased level of 
albumin in male rats when treated with a dose of 45 mg/kg. We referred that to 
the difference between the two doses. Ivermectin treated animals showed  
significant increase in day one, this finding is in agreement with Seri et al 
(2006), who reported significant increase in day 2 post treatment with 
Doramectin in donkeys and also in horses Herd et al (1985) reported similar 
results. 
Urea concentration showed no significant difference in the groups treated 
with Albendazole with the tow doses and Ivermectin.  Herd and Kociba (1985) 
reported that in horses treated with Ivermectin and also Seri et al., (2006) in 
donkeys treated with Doramectin had different result which revealed significant 
increase and decrease of Urea some sampling times. We may refer this to the 
tow different routes of administration which affected the bioavailability of the 
drugs. 
Serum creatine concentration was decreased in two occasions 
respectively on days 3 and 7 for the animals treated with Albendazole at two 
doses. 
In this study serum calcium concentration showed significant increase in 
two occasions on days 1and 3, respectively, then a significant decrease once in 
day 14 for Albendazole recommended dose treated group and also significant 
increase in days 7 and 14 for Albendazole treated twice. Martin (1980) observed 
that at dose of 6 - 62 mg/kg bw albendazole a skeletal abnormalities were 
increased and external malformations and major malformations were cranio-
facial and bone defects in rats.  No significant difference in calcium level in 
Ivermectin treated group and this is in harmony with Seri et al., (2006). 
Serum inorganic phosphorus concentration in the animals treated with 
double dose of Albendazole showed significant increase in day 14. No 
significant differences in inorganic phosphorus level in Ivermectin treated 
group, this is not in harmony with Seri et al., (2006) and Herd and Kociba 
(1985).  We attributed this to the different route of administration for the drug 
between the studies. 
 At the end we may conclude that administration of albendazole and 
Ivermectin did not show any toxic or adverse effects on liver and kidney 
functions. 
  
 
 
 
CHAPTER FIVE 
Chapter five 
Conclusion and Recommendation 
5.1 Conclusion 
              In this study we throw light on some equine gastrointestinal proplems 
of helminth nematodes in South Darfur State, the study is composed of three 
aspects. 
            The first one, was the survey conducted for a whole yaer, a total number 
of 1256 animals ( 446 horses and 810 donkeys) were examined to determine the 
overall prevalnce of gastro-intestinal nematodes, which was 29.20%, the 
prevalence in horses was 15.37% and in donkeys reported to be 37.48% . The 
second aspect was to evaluate the therapeutic efficacy of Albendazole drench 
formulation and to compare the obtained results with a commercial formulation 
of Ivermectin drench formulation against gastro-intestinal nematodes; 
Albendazole when used in the single dose expressed mean efficacy of 97.46% 
and 98.55% with the two doses administered at 14 days apart, while Ivermectin 
showed mean efficacy of 99.06% against gastro- intestinal nematodes. The third 
aspect was to evaluate the effect of medication with Albendazole and 
Ivermectin in donkeys naturally infected with gastro-intestinal nematode. 
Fortunately the three dose protocols showed no adverse or untoward effects in 
blood biochemical constituents. 
5.2 Recommendations 
1- Donkeys need more attention to apply stratigic programmes for 
controling gastro-intestinal nematodes what makes donkeys more healthy 
and productive.  
2- Scheduled deworming programmes should be designed and appllied on 
three occasions every year viz:  january, july and october including both 
donkeys and horses. 
3- Deworming portocols should start with Ivermectine drench followed by 
Albendazole suspention and finish with Ivermectin drench. 
4- The new anthelmintic drugs (Doramectin, Abmectin and Moxidectin) 
should be tested and used in equines. 
5‐ Research institues should encourage studies in both  sudanese donkeys 
and horses in the coming future. 
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